Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10967679 | 0.85 | ALDH1A1 (0.54) | ALDH1A1KMT2ARECQLCA2CA9 | |
| SCHEMBL1346520 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KMT2ACA2CA9CA12 | |
| SCHEMBL2178479 | 0.84 | KMT2A (0.78) | ALDH1A1KMT2ARECQLCA2CA9 | |
| SCHEMBL17550651 | 0.84 | GAA (0.53) | ALDH1A1KMT2ACA2CA9CA12 | |
| SCHEMBL13299623 | 0.84 | PLCG1 (0.52) | ALDH1A1KMT2ARECQLCA2CA1 | |
| SCHEMBL2069531 | 0.84 | SMN1; SMN2 (0.52) | ALDH1A1KMT2ACA2CA9CA12 | |
| SCHEMBL1346537 | 0.84 | HTT (0.58) | ALDH1A1KMT2ACA2CA1PKM | |
| SCHEMBL602 | 0.83 | HSD11B1 (0.59) | ALDH1A1KMT2AHSD11B1MAPTHSD17B10 | |
| SCHEMBL23049753 | 0.82 | KMT2A (0.53) | ALDH1A1KMT2ACA2 | |
| SCHEMBL3282087 | 0.82 | ALDH1A1 (0.64) | ALDH1A1KMT2ARECQLCA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213266-A | Synthesis process of high-purity D-N- (2, 6-xylyl) alanine methyl ester | 浙江禾本科技股份有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-120988477-B | Microporous high-magnification polyethersulfone foam material for electromagnetic shielding and mould pressing foaming preparation method thereof | 东营瑞致新材料有限公司 | 2026-04-14 | — | — | CN | disclosed |
| CN-120988477-A | Microporous high-magnification polyethersulfone foam material for electromagnetic shielding and mould pressing foaming preparation method thereof | 东营瑞致新材料有限公司 | 2025-11-21 | — | — | CN | disclosed |
| WO-2024217500-A1 | ISOQUINOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 上海赛默罗生物科技有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-114213266-B | Synthesis process of high-purity D-N- (2, 6-xylyl) alanine methyl ester | 浙江禾本科技股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20230321016-A1 | COMBINATION THERAPY FOR TREATING CANCER | GONGWIN BIOPHARM CO., LTD (TW) | 2023-10-12 | — | — | US | disclosed |
| US-11752160-B2 | Method for reducing fat by administering benzenesulfonamide compositions | GONGWIN BIOPHARM CO., LTD (TW) | 2023-09-12 | — | — | US | disclosed |
| US-11752118-B2 | Method for treating melanoma | GONGWIN BIOPHARM CO., LTD (TW) | 2023-09-12 | — | — | US | disclosed |
| CN-111212833-B | Phenylpyridine derivatives and pharmaceutical compositions containing the same | 株式会社大熊制药 | 2022-09-06 | — | — | CN | disclosed |
| EP-3696176-B1 | NOVEL PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | DAE WOONG PHARMA (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-20170172951-A1 | NOVEL PHARMACEUTICAL COMPOSITIONS OF BENZENESULFONAMIDE DERIVATIVES FOR TREATMENT OF ADENOID CYSTIC CARCINOMA | GONGWIN BIOPHARM CO., LTD. (TAIWAN) (TW) | 2017-06-22 | — | — | US | disclosed |
| US-20170045820-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING THE SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-16 | — | — | US | disclosed |
| CN-101023089-B | Silane merocyanine sulphone derivatives, photoprotecting compositions containing same, use thereof as UV filter | OREAL | 2013-11-06 | — | — | CN | disclosed |
| US-7510703-B2 | UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones | L'OREAL (FR) | 2009-03-31 | — | — | US | disclosed |
| US-20070224147-A1 | UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones | L'OREAL (FR) | 2007-09-27 | — | — | US | disclosed |
| CN-101023089-A | Silane merocyanine sulphone derivatives, photoprotecting compositions containing same, use thereof as UV filter | OREAL (FR) | 2007-08-22 | — | — | CN | disclosed |
| US-7244859-B2 | Method for producing δ-aminopentadienoate derivatives | FUJIFILM CORPORATION (JP) | 2007-07-17 | — | — | US | disclosed |
| EP-0111997-B1 | VINYL CARBOXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4518602-A | Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-05-21 | — | — | US | disclosed |
| EP-0111997-A2 | Vinyl carboxylic acid derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170172951-A1 | NOVEL PHARMACEUTICAL COMPOSITIONS OF BENZENESULFONAMIDE DERIVATIVES FOR TREATMENT OF ADENOID CYSTIC CARCINOMA | ABCD3, CFTR, ADSL | ALDH1A1 1243/4885KMT2A 3531/4885RECQL 31/4885 |
| US-11752160-B2 | Method for reducing fat by administering benzenesulfonamide compositions | LIPE, FABP4, LIPA | ALDH1A1 728/4885KMT2A 2032/4885RECQL 1843/4885 |
| US-20070224147-A1 | UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones | ERCC1, ERCC5, CRY1 | ALDH1A1 227/4885KMT2A 2703/4885RECQL 1275/4885 |
| US-20230321016-A1 | COMBINATION THERAPY FOR TREATING CANCER | TP53, MCL1, TOP2B | ALDH1A1 381/4885KMT2A 1380/4885RECQL 390/4885 |
| US-11752118-B2 | Method for treating melanoma | TYR, MITF, BRAF | ALDH1A1 528/4885KMT2A 1442/4885RECQL 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.